Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

ANGIOTECH PHARMACEUTICALS INC (ANPMF) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-12Dec-31-11Apr-30-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06
Revenues243.8153.080.3246.2279.7283.3287.7315.1
            Revenue growth59.4%-37.9% -12.0%-1.3%-1.5%-8.7% 
Cost of goods sold102.790.332.2106.3104.6101.194.969.5
Gross profit141.162.648.0139.9175.1182.2192.7245.5
            Gross margin57.9%40.9%59.9%56.8%62.6%64.3%67.0%77.9%
Selling, general and administrative71.060.424.889.281.598.599.378.9
Research and development7.114.15.726.823.753.254.045.4
EBITA60.0-51.52.3-20.123.1-668.7-20.759.2
            EBITA margin24.6%-33.6%2.9%-8.1%8.3%-236.1%-7.2%18.8%
Amortization of intangibles32.0       
EBIT28.0-51.52.3-20.123.1-668.7-20.759.2
            EBIT margin11.5%-33.6%2.9%-8.1%8.3%-236.1%-7.2%18.8%
Pre-tax income2.0-63.4379.8-66.9-16.8-754.1-70.612.8
Income taxes8.2-3.00.30.06.0-12.9-4.72.1
            Tax rate413.8%4.7%0.1%0.1% 1.7%6.6%16.3%
Earnings from continuing ops-6.2-60.4379.5-66.8-22.9-741.2-65.910.7
Earnings from discontinued ops       -7.7
Net income-6.2-60.4379.5-66.8-22.9-741.2-65.910.7
            Net margin-2.6%-39.5%472.8%-27.1%-8.2%-261.6%-22.9%3.4%
 
Diluted EPS($0.49)($4.82)$4.46($0.78)($0.27) ($0.78)$0.13
Shares outstanding (diluted)12.812.585.285.285.1 84.585.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy